Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Ulcerative Colitis (UC) Is Among The Most Common Inflammatory Bowel Diseases, Affecting One In A Thousand People With Debilitating Symptoms

New Survey Brings Attention to Chronic Ulcerative Colitis (UC), VSL#3®, a High-Potency Probiotic Medical Food for the Dietary Management of UC, May Offer Relief

VSL#3

News provided by

VSL#3

Jul 29, 2015, 08:10 ET

Share this article

Share toX

Share this article

Share toX

GAITHERSBURG, Md., July 29, 2015 /PRNewswire/ -- Ulcerative colitis (UC), an inflammatory bowel disease that affects one in every 1,000 Americans who are often diagnosed before age 30, can make carrying out the simplest of activities, like going to work or the grocery store, difficult. In fact, a recent online survey among 607 adults diagnosed with either Irritable Bowel Syndrome (IBS), UC or ileal pouch/pouchitis, including 92 with UC conducted by Harris Poll on behalf of VSL#3 in April, 78%1 of UC sufferers said their condition interfered with their life and 43%2 identify their condition as extremely or very problematic.

Patsy Catsos, a registered dietician who has had UC for the past 30 years, is a huge proponent of VSL#3®.  She began serving as a nutrition consultant for the high-potency probiotic medical food that is clinically proven in the dietary management of ulcerative colitis or an ileal pouch. Catsos says she eventually found relief when she and her gastroenterologist figured out the right management/dietary plan, including a daily intake of VSL#3.

Today, Catsos, who has maintained her UC remission for the past 15 years, recalls her personal struggle:  "I was really struggling when my children were young. It was practically impossible to take my children to a playground or beach, travel, go for a hike, or do anything without close proximity to a restroom. At the time, I wasn't even able to work and had to use my limited energy to keep my kid's lives normal and keep the family running smoothly. As a young adult and medical nutrition therapist, I felt paralyzed and like a failure for not being able to get my condition under control through nutrition alone."

Unfortunately, says board certified gastroenterologist, Patricia Raymond, MD, it's not uncommon for those with UC to experience five to 30 bowel movements per day, rectal pain from too much "traffic", excess gas and painful abdominal cramps, ranging from mild to severe. "We're not sure what causes UC, but some believe it may be caused by vulnerabilities related to a hyper-reactive immune system and the gut microbiome is also likely to be involved," she adds.

"There is no known cure for ulcerative colitis," says Raymond, MD, who recommends VSL#3 to her UC patients as part of their UC management. "Dealing with UC can be frustrating, since patients respond differently to different products, but it's important that they and their physician – such as a gastroenterologist who specializes in intestinal issues and diseases – find ways to best manage their symptoms."

In addition to making dietary changes, Dr. Raymond says it's also imperative sufferers make positive lifestyle changes, including getting adequate rest, exercise and keeping stress under control to help maintain remission. And, while there isn't a one size-fits-all-solution when it comes to managing UC, VSL#3 has been clinically studied to show that when added to traditional therapies, it helps maintain remission in patients with mild to moderate UC3.

"Finding the proper treatment plan truly makes a world of difference for people with this chronic condition that can not only help improve their symptoms, but help minimize disruptions from this condition in their life. To be able to enjoy your family, or have the confidence to complete a day of work without embarrassment due to frequent and sometimes urgent trips to the restroom, is a source of empowerment for those managing UC patients," Dr. Raymond adds. She also stresses that it's important for those with UC to understand that not all probiotics and bacterial strains are the same4. As discovered in this recent study, 69%5 of UC sufferers agreed they do not know what to look for when choosing a probiotic.

Unlike most probiotic dietary supplements filling store shelves, VSL#3 is a medical food and is backed up with several clinical studies. It is at least 10 times more potent than the average probiotic and is formulated with eight strains of live, freeze-dried lactic acid bacteria that require refrigeration to maintain their potency. "Adding VSL#3 to the dietary management of UC patients can make all the difference," Dr. Raymond adds.

To connect with the VSL#3 online community, go to www.facebook.com/vsl3probiotic or visit www.vsl3.com. Ask your health care provider or pharmacist about VSL#3, which is available in pharmacies nationwide and online at www.vsl3.com. VSL#3 is distributed in the U.S. by Sigma-Tau Pharmaceuticals, Inc. of Gaithersburg, Maryland 20878.

Survey Methodology: Harris Poll conducted the GI Issues Survey on behalf of VSL#3. The survey was administered online within the United States between April 1 - 7, 2015 among 607 adults ages 18+ who have been diagnosed with a digestive or gastrointestinal condition, irritable bowel syndrome, or ulcerative colitis, ileal pouch/pouchitis ("sufferers"). Among the 607 adults ages 18+, 92 reported a diagnosis of UC. It has been noted in the contents of this release where small sample data was used. Data are weighted where necessary by age within gender, race/ethnicity, region, education, income, and propensity to be online to bring them in line with their actual proportions in the population. For more information about the study please contact Ashley Hughes at [email protected].

1 Caution-small base (n<100). Results should be interpreted as qualitative, or directional, in nature.
2 Caution-small base (n<100). Results should be interpreted as qualitative, or directional, in nature.
3 Inflamm Bowel Dis _ Volume 0, Number 0, Month 2014
4 Bertazzoni, et al. Journal of Chemotherapy.25.4.193-212 (2013); Fedorak RN, J Clin Gastroenterol. 42:S3; S111-115 (2008); Lammers KM, et al. FEMS Immunol Med Microbiol. 38:165-72 (2003)
5 Caution- small base (n<100). Results should be interpreted as qualitative, or directional, in nature.

Logo - http://photos.prnewswire.com/prnh/20150728/248028LOGO

SOURCE VSL#3

Related Links

http://www.vsl3.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.